loadpatents
name:-0.01519513130188
name:-0.008965015411377
name:-0.0077939033508301
Childs; Bennett G. Patent Filings

Childs; Bennett G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Childs; Bennett G..The latest application filed is for "treating cardiovascular disease by selectively eliminating senescent cells".

Company Profile
8.7.16
  • Childs; Bennett G. - Rochester MN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treating Cardiovascular Disease By Selectively Eliminating Senescent Cells
App 20210169875 - Laberge; Remi-Martin ;   et al.
2021-06-10
Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor
Grant 10,517,866 - Laberge , et al. Dec
2019-12-31
Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye
Grant 10,478,432 - Laberge , et al. Nov
2019-11-19
Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss
Grant 10,478,433 - Laberge , et al. Nov
2019-11-19
Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase
Grant 10,413,542 - Laberge , et al. Sept
2019-09-17
Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques
Grant 10,328,058 - Baker , et al.
2019-06-25
Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells
Grant 10,328,073 - Laberge , et al.
2019-06-25
Protocol For Increasing Life Expectancy In A Test Subject
App 20190022225 - Baker; Darren J. ;   et al.
2019-01-24
Use Of Sulfonamide Inhibitors Of Bcl-2 And Bcl-xl To Treat Ophthalmic Disease By Selectively Removing Senescent Cells
App 20190022090 - Laberge; Remi-Martin ;   et al.
2019-01-24
Pharmaceutical Products and Drug Combinations for Treating Atherosclerosis by Stabilizing Atherosclerotic Plaques and Promoting Plaque Regression
App 20190000846 - van Deursen; Jan M.A. ;   et al.
2019-01-03
Methods and Compositions for Killing Senescent Cells and for Treating Senescence-Associated Diseases and Disorders
App 20180256568 - Laberge; Remi-Martin ;   et al.
2018-09-13
Removing Senescent Cells From A Mixed Cell Population Or Tissue Using A Phosphoinositide 3-kinase (pi3k) Inhibitor
App 20180250296 - Laberge; Remi-Martin ;   et al.
2018-09-06
Treatment of Ophthalmic Conditions by Selectively Removing Senescent Cells from the Eye
App 20180235957 - Laberge; Remi-Martin ;   et al.
2018-08-23
Compositions And Methods For Treating Senescence-associated Diseases And Disorders
App 20180193458 - Lopez-Dominguez; Jose Alberto ;   et al.
2018-07-12
Treatment of ophthalmic conditions by selectively removing senescent cells from the eye
Grant 10,010,546 - Laberge , et al. July 3, 2
2018-07-03
Treating Atherosclerosis By Removing Senescent Foam Cell Macrophages From Atherosclerotic Plaques
App 20180104222 - Childs; Bennett G. ;   et al.
2018-04-19
Methods And Compositions For Killing Senescent Cells And For Treating Senescence-associated Diseases And Disorders
App 20170348307 - Laberge; Remi-Martin ;   et al.
2017-12-07
Methods And Compositions For Killing Senescent Cells And For Treating Senescence-associated Diseases And Disorders
App 20170224680 - Laberge; Remi-Martin ;   et al.
2017-08-10
Methods And Compositions For Killing Senescent Cells And For Treating Senescence-associated Diseases And Disorders
App 20170209435 - Laberge; Remi-Martin ;   et al.
2017-07-27
Methods And Compositions For Killing Senescent Cells And For Treating Senescence-associated Diseases And Disorders
App 20170196858 - Laberge; Remi-Martin ;   et al.
2017-07-13
Methods And Compositions For Killing Senescent Cells And For Treating Senescence-associated Diseases And Disorders
App 20170198253 - Laberge; Remi-Martin ;   et al.
2017-07-13
Methods And Compositions For Killing Senescent Cells And For Treating Senescence-associated Diseases And Disorders
App 20170196857 - Laberge; Remi-Martin ;   et al.
2017-07-13
Methods And Compositions For Killing Senescent Cells And For Treating Senescence-associated Diseases And Disorders
App 20160339019 - Laberge; Remi-Martin ;   et al.
2016-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed